"Oligometastatic disease" trang 1 - tải miễn phí từ tailieunhanh
Proposal for a definition of

Proposal for a definition of "Oligometastatic disease in pancreatic cancer"
13    64    0
Systemic and tumor-directed therapy for oligometastatic prostate cancer: Study protocol for a phase II trial for veterans with de novo oligometastatic disease

Systemic and tumor-directed therapy for oligometastatic prostate cancer: Study protocol for a phase II trial for veterans with de novo oligometastatic disease
6    34    1
Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer

Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer
8    45    1
Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: A safe and effective approach

Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: A safe and effective approach
8    30    1
Phase II study of multidisciplinary therapy combined with pembrolizumab for patients with synchronous oligometastatic nonsmall cell lung cancer TRAP OLIGO study (WJOG11118L)

Phase II study of multidisciplinary therapy combined with pembrolizumab for patients with synchronous oligometastatic nonsmall cell lung cancer TRAP OLIGO study (WJOG11118L)
6    38    1
Solitary acrometastasis of the phalanx as initial presentation of an oligometastatic Kirsten rat sarcoma viral oncogene homolog-mutated lung adenocarcinoma: A case report

Solitary acrometastasis of the phalanx as initial presentation of an oligometastatic Kirsten rat sarcoma viral oncogene homolog-mutated lung adenocarcinoma: A case report
4    16    1
Oligo-metastatic neoPlasms from the gastrointestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: The PREDICTION study

Oligo-metastatic neoPlasms from the gastrointestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: The PREDICTION study
9    6    1
Chemoradiotherapy with concurrent durvalumab for the palliative treatment of oligometastatic oesophageal and gastrooesophageal carcinoma with dysphagia: A single arm phase II clinical trial (PALEO, sponsored by the Australasian Gastro-Intestinal Trials Group)

Chemoradiotherapy with concurrent durvalumab for the palliative treatment of oligometastatic oesophageal and gastrooesophageal carcinoma with dysphagia: A single arm phase II clinical trial (PALEO, sponsored by the Australasian Gastro-Intestinal Trials Group)
10    4    1
Local ablation or radioembolization of colorectal cancer metastases: Comorbidities or older age do not affect overall survival

Local ablation or radioembolization of colorectal cancer metastases: Comorbidities or older age do not affect overall survival
9    66    1